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The human genome contains nearly 400,000 sequences
related to retroviruses that have accumulated due to
ancient infections of the germ line and subsequent fixa-
tion during evolution. Most of these endogenous retro-
viral sequences (ERVs) currently exist as solitary long
terminal repeats (LTRs), the product of recombination
between LTRs of the integrated proviral form. Since ret-
roviral LTRs naturally contain transcriptional promoters
and enhancers, these sequences have great potential to
impact regulation of individual genes and gene regula-
tory networks. Numerous cases of LTRs serving as pro-
moters for human genes have been described by our
group and others, and some examples will be presented.
While such co-option of LTRs as regulatory gene mod-
ules indeed occurs in normal cells, particularly in pla-
centa or in early development, transcriptional activity of
most endogenous LTRs is epigenetically suppressed in
somatic tissues, likely as a host defense against unregu-
lated transcription. Cancer cells represent an abnormal
epigenetic environment where LTRs and other classes of
transposable elements (TEs) are often hypomethylated,
leading to their transcriptional activation. This activation
could result in abnormal, cancer-specific expression of
nearby genes. To study this phenomenon, we are analyz-
ing whole transcriptome data of cancers specifically to
identify gene deregulation due to transcriptional activity
of LTRs or other TEs. Our results suggest that the regu-
latory potential of these sequences is often used by can-
cer cells, providing one avenue to up-regulate genes.
Thus, while some LTRs/TEs have been co-opted to
serve in normal gene expression, the same regulatory
qualities can be exploited in carcinogenesis.
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